M Mueller

Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy

Enza Lonardo, Patrick Hermann, M Mueller et al. · Cell stem cell · 2011 · 412 citations · Full text

Lineage Plasticity, Pancreatic Cancer, Combined Drug Therapy +9

Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer

M Mueller, Patrick Hermann, Juliane Witthauer et al. · Gastroenterology · 2009 · 346 citations · Full text

Cell Therapy, Pancreatic Cancer, Targeted Treatment +9

Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction

Eike Gallmeier, Patrick Hermann, M Mueller et al. · Stem Cells · 2011 · 103 citations · Full text

Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment1

Vadym Getman, Elena Devyatko, Daniela Dunkler et al. · European Journal of Cardio-Thoracic Surgery · 2004 · 44 citations

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

Daniel Cejka, Claudia Kuntner, Matthias Preusser et al. · British Journal of Cancer · 2009 · 39 citations · Full text